Data / Form D filings / HedgePath Pharmaceuticals, Inc.
HedgePath Pharmaceuticals, Inc.: Form D filing
HedgePath Pharmaceuticals, Inc., a pharmaceuticals company in Tampa, FL, filed a Form D with the SEC in 2016. The latest, on April 22, 2016, reports $600,000 sold of a $5.5 million offering to 3 investors.
Find out what HedgePath Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 324 SOUTH HYDE PARK AVENUE, SUITE 350, Tampa, FL, 33606
- Phone
- (813) 864-2559
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1042418
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2016 | New notice | $5,500,000 | $600,000 | $4,900,000 | 3 | Apr 11, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samuel P. Sears, Jr. | Director | |
| R. Dana Ono, MD | Director | |
| Frank E. O'Donnell, Jr., MD | Executive Officer, Director | |
| Nicholas J. Virca | Executive Officer | |
| W. Mark Watson, CPA | Director | |
| Garrison J. Hasara, CPA | Executive Officer | |
| Stefan J. Cross | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Apr 18, 2016 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HedgePath Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.